| First Author | Rabinovich-Nikitin I | Year | 2022 |
| Journal | Cells | Volume | 11 |
| Issue | 14 | PubMed ID | 35883637 |
| Mgi Jnum | J:332334 | Mgi Id | MGI:7325800 |
| Doi | 10.3390/cells11142193 | Citation | Rabinovich-Nikitin I, et al. (2022) NF-kappaB p65 Attenuates Cardiomyocyte PGC-1alpha Expression in Hypoxia. Cells 11(14) |
| abstractText | Hypoxia exerts broad effects on cardiomyocyte function and viability, ranging from altered metabolism and mitochondrial physiology to apoptotic or necrotic cell death. The transcriptional coactivator peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1alpha) is a key regulator of cardiomyocyte metabolism and mitochondrial function and is down-regulated in hypoxia; however, the underlying mechanism is incompletely resolved. Using primary rat cardiomyocytes coupled with electrophoretic mobility shift and luciferase assays, we report that hypoxia impaired mitochondrial energetics and resulted in an increase in nuclear localization of the Nuclear Factor-kappaB (NF-kappaB) p65 subunit, and the association of p65 with the PGC-1alpha proximal promoter. Tumor necrosis factor alpha (TNFalpha), an activator of NF-kappaB signaling, similarly reduced PGC-1alpha expression and p65 binding to the PGC-1alpha promoter in a dose-dependent manner, and TNFalpha-mediated down-regulation of PGC-1alpha expression could be reversed by the NF-kappaB inhibitor parthenolide. RNA-seq analysis revealed that cardiomyocytes isolated from p65 knockout mice exhibited alterations in genes associated with chromatin remodeling. Decreased PGC-1alpha promoter transactivation by p65 could be partially reversed by the histone deacetylase inhibitor trichostatin A. These results implicate NF-kappaB signaling, and specifically p65, as a potent inhibitor of PGC-1alpha expression in cardiac myocyte hypoxia. |
